Us Congress 2023-2024 Regular Session

Us Congress House Bill HB455

Introduced
1/24/23  
Refer
1/24/23  
Refer
2/3/23  

Caption

This bill makes technical corrections in the definitions section of the Controlled Substances Act.

Impact

The impact of HB455 on state laws centers around the definitions of various drug-related terms, which are crucial for establishing legal frameworks in the prosecution of drug offenses. By correcting errors and aligning definitions with practical usage, the bill aims to prevent misunderstandings and misapplications of the law. This technical amendment can lead to more consistent legal proceedings and outcomes in drug-related cases, potentially influencing how courts interpret and apply the law moving forward.

Summary

House Bill 455 is a legislative proposal aimed at amending the Controlled Substances Act, specifically to rectify a technical error found within the definitions section. The bill seeks to enhance clarity and precision by redesignating existing definitions, ensuring that legal interpretations align with current legislative intent. This clarification is deemed essential for the proper enforcement and application of drug-related laws across the United States.

Sentiment

General sentiment regarding HB455 appears to be supportive among legislators, as it addresses a clear technical issue that could affect legal clarity and operations. Stakeholders in the legal and law enforcement communities recognize the necessity of such adjustments to maintain the integrity of the Controlled Substances Act. There seems to be an understanding that technical corrections play a vital role in ensuring the effectiveness of legislation, with less opposition typically seen for non-controversial amendments of this nature.

Contention

While HB455 focuses on technical corrections rather than substantive policy changes, the discussions surrounding such amendments often reflect broader issues in drug policy and enforcement. Notable points of contention could arise should this bill be perceived as an attempt to alter the foundational aspects of drug regulations, though the current scope seems narrowly focused. Nevertheless, any changes to the Controlled Substances Act can spark debates on the ongoing evolution of drug legislation and its implications for state and federal law enforcement.

Companion Bills

US SB223

Related bill A bill to amend the Controlled Substances Act to fix a technical error in the definitions.

Previously Filed As

US SB223

A bill to amend the Controlled Substances Act to fix a technical error in the definitions.

US HB1393

To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.

US HB1504

Apex Area Technical Corrections Act

US HB4490

To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the ultimate user, and for other purposes.

US HB171

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

US HB3578

To make technical amendments to update statutory references to provisions reclassified to title 34, United States Code, and to correct related technical errors.

US SB311

U.S. Customs and Border Protection Officer Retirement Technical Corrections Act

US HB432

Buy Low and Sell High Act This bill revises requirements concerning the Strategic Petroleum Reserve (SPR) and sets forth provisions to reduce the demand for petroleum fuel and increase fuel supply. For example, the bill directs the Department of Energy (DOE) to establish within the SPR an Economic Petroleum Reserve of up to 350 million barrels of crude oil. DOE must also establish a national network of Strategic Refined Petroleum Product Reserves to store up to 250 million barrels of gasoline and diesel fuel, which may be sold when there is a severe fuel supply interruption within the district in which the reserve is located. In addition, the bill increases the cap on the amount of barrels of petroleum distillate that may be stored in the Northeast Home Heating Oil Reserve from two million to four million. It also establishes limits on the sale and exportation of petroleum products from such reserves. Further, the bill establishes provisions concerning electrifying the transportation sector, zero-emission vehicles, and a program to increase the amount of crude oil refined in oil refineries in certain countries in the Western Hemisphere.

US HB70

Freedom for Farmers Act of 2023 This bill abolishes the Agency for Toxic Substances and Disease Registry. This agency, which is part of the Department of Health and Human Services (HHS), investigates and responds to environmental exposures to hazardous substances in communities. HHS must transfer authority regarding certain national disease and toxic exposure registries to another appropriate HHS entity.

US HB3570

Comprehensive Response to Fentanyl-Related Substances and Fentanyl-Laced Substances Act

Similar Bills

No similar bills found.